This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The University of British Columbia, Other. Active years: 2010-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 963 
2 out of 834,570 Years Active: 2010-2022
Title: The Innovative Mind of Kelly Marshall McNagny: A Pioneer in Cancer Treatment
Introduction: Kelly Marshall McNagny, a prominent inventor based in Vancouver, Canada, has made significant contributions to the field of biomedicine. With four patents to his name, his work primarily focuses on developing innovative solutions for cancer treatment. His research and inventions are instrumental in advancing therapeutic strategies aimed at improving patient outcomes.
Latest Patents: Among McNagny's notable inventions are two key patents related to anti-podocalyxin antibodies. The first patent, titled "Anti-podocalyxin antibodies and methods of using the same," introduces compositions that are valuable for treating cancer in mammals. This patent details the use of specific antibodies, designated Ab1 and 3G2, which inhibit the growth of tumors expressing podocalyxin and target tumor endothelial cells that exhibit this protein. His second patent, also on "Anti-podocalyxin antibodies and methods of using the same," expands on this groundwork, outlining compositions and methods for the prevention, diagnosis, and treatment of cancer.
Career Highlights: McNagny's career is marked by his affiliation with the University of British Columbia, where he has utilized his expertise to enhance cancer research and treatment methodologies. His innovative spirit and dedication to advancing science have positioned him as a leading figure in biomedical research.
Collaborations: Throughout his career, McNagny has worked closely with esteemed colleagues, including Calvin D. Roskelley and Helen Merkens. Their collaborative efforts have helped to shape the landscape of cancer treatment research, driving breakthroughs that hold the promise of improving clinical outcomes for patients.
Conclusion: Kelly Marshall McNagny's contributions to the field of cancer treatment through his inventive spirit and collaborative work exemplify the impact that dedicated researchers can have on society. With his patents paving the way for new therapeutic approaches, McNagny continues to be a beacon of innovation in the medical community. His efforts not only enhance our understanding of cancer biology but also open new avenues for effective treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile